🇺🇸 FDA
Patent

US 10730854

Therapeutically active compounds and their methods of use

granted A61KA61K31/444A61K31/53

Quick answer

US patent 10730854 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
72
CPC classes
A61K, A61K31/444, A61K31/53, A61K9/2054, A61K9/2059